Real-World Outcomes In Patients With Chronic Hepatitis C Virus Infection And Substance Abuse Disorders Treated With Glecaprevir/Pibrentasvir For 8 Weeks: A Pooled Analysis Of Multinational Post-Marketing Observational Studies

HEPATOLOGY(2020)

引用 0|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要